$Evoke Pharma(EVOK)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001209191-20-032964 Size: 5 KB 网页链接
$Evoke Pharma(EVOK)$ 8-K Current report, item 5.07 Accession Number: 0001564590-20-027126 Act: 34 Size: 56 KB 网页链接
$Evoke Pharma(EVOK)$ 8-K Current report, item 8.01 Accession Number: 0001564590-20-026257 Act: 34 Size: 39 KB 网页链接
$Evoke Pharma(EVOK)$ DEFA14A Additional definitive proxy soliciting materials and Rule 14(a)(12) material Accession Number: 0001564590-20-024766 Act: 34 Size: 214 KB 网页链接
$Evoke Pharma(EVOK)$ DEFA14A Additional definitive proxy soliciting materials and Rule 14(a)(12) material Accession Number: 0001564590-20-024528 Act: 34 Size: 54 KB 网页链接
$Evoke Pharma(EVOK)$ 10-Q Quarterly report [Sections 13 or 15(d)] Accession Number: 0001564590-20-024523 Act: 34 Size: 2 MB 网页链接
$Evoke Pharma(EVOK)$ 8-K Current report, items 2.02 and 9.01 Accession Number: 0001564590-20-024527 Act: 34 Size: 230 KB 网页链接
$Evoke Pharma(EVOK)$ DEFA14A Additional definitive proxy soliciting materials and Rule 14(a)(12) material Accession Number: 0001564590-20-016566 Act: 34 Size: 157 KB 网页链接
$Evoke Pharma(EVOK)$ DEF 14A Other definitive proxy statements Accession Number: 0001564590-20-016563 Act: 34 Size: 1 MB 网页链接
$Evoke Pharma(EVOK)$ 8-K Current report, items 2.02 and 9.01 Accession Number: 0001564590-20-010253 Act: 34 Size: 219 KB 网页链接